Wealth Alliance Abb Vie Inc. Transaction History

Wealth Alliance

$818 Million
Q3 2024

A detailed history of Wealth Alliance transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Alliance holds 21,893 shares of ABBV stock, worth $3.91 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

21,893

Previous 21,817 0.35%

Holding current value

$3.91 Million

Previous $3.74 Million 15.53%

% of portfolio

0.53%

Previous 0.49%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$163.84 - $199.33 $12,451 - $15,149	76 Added 0.35%	21,893 $4.32 Million
Q2 2024 Aug 09, 2024	SELL	$154.79 - $180.76 $10,370 - $12,110	-67 Reduced 0.31%	21,817 $3.74 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $614,827 - $700,538	-3,847 Reduced 14.95%	21,884 $3.99 Million
Q4 2023 Jan 30, 2024	BUY	$137.6 - $154.97 $287,721 - $324,042	2,091 Added 8.85%	25,731 $3.99 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $121,299 - $140,422	908 Added 3.99%	23,640 $3.52 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $187,236 - $233,003	-1,413 Reduced 5.85%	22,732 $3.06 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $62,905 - $72,444	-435 Reduced 1.77%	24,145 $3.85 Million
Q4 2022 Feb 13, 2023	BUY	$138.31 - $165.87 $110,371 - $132,364	798 Added 3.36%	24,580 $3.97 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $73,949 - $84,815	-551 Reduced 2.26%	23,782 $3.19 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $103,215 - $131,220	750 Added 3.18%	24,333 $3.73 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $155,868 - $193,388	1,181 Added 5.27%	23,583 $3.82 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $31,799 - $40,235	296 Added 1.34%	22,402 $3.03 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $61,499 - $69,810	578 Added 2.68%	22,106 $2.39 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $193,586 - $215,666	1,840 Added 9.35%	21,528 $2.43 Million
Q1 2021 May 18, 2021	BUY	$102.3 - $112.62 $60,561 - $66,671	592 Added 3.1%	19,688 $2.13 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $103,590 - $139,858	1,287 Added 7.23%	19,096 $2.05 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $5,841 - $6,856	68 Added 0.38%	17,809 $1.56 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $334,200 - $447,209	4,555 Added 34.54%	17,741 $1.74 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $130,161 - $197,340	2,018 Added 18.07%	13,186 $1.01 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $734,211 - $918,654	10,179 Added 1029.22%	11,168 $989,000
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $71,336 - $89,257	989 New	989 $989,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.

Account